Search research articles
Contact Us
Filters
Showing results (21-30 of 55) with videos related to
Page
of 6
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 5, 1999
Impaired fasting glucose is not a risk factor for atherosclerosis
M Hanefeld, T Temelkova-Kurktschiev, F Schaper, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|
May 29, 2000
Prevalence and atherosclerosis risk in different types of non-diabetic hyperglycemia. Is mild hyperglycemia an underestimated evil?
T Temelkova-Kurktschiev, E Henkel, F Schaper, et al.
Diabetologia
|
May 20, 1999
Is the newly suggested fasting plasma glucose cut-off point for the diagnosis of diabetes the right one?
C Koehler, T Temelkova-Kurktschiev, E Henkel, et al.
Atherosclerosis
|
June 25, 1999
Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals
M Hanefeld, C Koehler, F Schaper, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
February 13, 2001
Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Risk Factors in Impaired Glucose Tolerance for Atherosclerosis and Diabetes
M Hanefeld, C Koehler, E Henkel, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
December 9, 2008
Effects of the alpha glucosidase inhibitor acarbose on endothelial function after a mixed meal in newly diagnosed type 2 diabetes
F Pistrosch, F Schaper, J Passauer, et al.
Diabetes/Metabolism Research and Reviews
|
January 15, 2000
Effect of glucagon on carbohydrate-mediated secretion of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-36 amide) (GLP-1)
L Ranganath, F Schaper, R Gama, et al.
The Journal of Biological Chemistry
|
April 15, 2000
The inhibition of interleukin-6-dependent STAT activation by mitogen-activated protein kinases depends on tyrosine 759 in the cytoplasmic tail of glycoprotein 130
L Terstegen, P Gatsios, J G Bode, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
February 14, 2009
Effect of acarbose on postmeal mononuclear blood cell response in patients with early type 2 diabetes: the AI(I)DA study
M Hanefeld, F Schaper, C Koehler, et al.
Trends in Genetics : TIG
|
June 1, 1995
Identification of mammalian cell clones exhibiting highly regulated expression from inducible promoters
S Kirchhoff, M Köster, M Wirth, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 55) with videos related to
Sort By:
Page
of 6
Diabetic Medicine : a Journal of the British Diabetic Association
|
May 5, 1999
Impaired fasting glucose is not a risk factor for atherosclerosis
M Hanefeld, T Temelkova-Kurktschiev, F Schaper, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|
May 29, 2000
Prevalence and atherosclerosis risk in different types of non-diabetic hyperglycemia. Is mild hyperglycemia an underestimated evil?
T Temelkova-Kurktschiev, E Henkel, F Schaper, et al.
Diabetologia
|
May 20, 1999
Is the newly suggested fasting plasma glucose cut-off point for the diagnosis of diabetes the right one?
C Koehler, T Temelkova-Kurktschiev, E Henkel, et al.
Atherosclerosis
|
June 25, 1999
Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals
M Hanefeld, C Koehler, F Schaper, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
February 13, 2001
Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Risk Factors in Impaired Glucose Tolerance for Atherosclerosis and Diabetes
M Hanefeld, C Koehler, E Henkel, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
December 9, 2008
Effects of the alpha glucosidase inhibitor acarbose on endothelial function after a mixed meal in newly diagnosed type 2 diabetes
F Pistrosch, F Schaper, J Passauer, et al.
Diabetes/Metabolism Research and Reviews
|
January 15, 2000
Effect of glucagon on carbohydrate-mediated secretion of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-36 amide) (GLP-1)
L Ranganath, F Schaper, R Gama, et al.
The Journal of Biological Chemistry
|
April 15, 2000
The inhibition of interleukin-6-dependent STAT activation by mitogen-activated protein kinases depends on tyrosine 759 in the cytoplasmic tail of glycoprotein 130
L Terstegen, P Gatsios, J G Bode, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
February 14, 2009
Effect of acarbose on postmeal mononuclear blood cell response in patients with early type 2 diabetes: the AI(I)DA study
M Hanefeld, F Schaper, C Koehler, et al.
Trends in Genetics : TIG
|
June 1, 1995
Identification of mammalian cell clones exhibiting highly regulated expression from inducible promoters
S Kirchhoff, M Köster, M Wirth, et al.
Page
of 6